Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.
By A. Henao-Restrepo, I. Longini, Matthias Egger, N. Dean, W. Edmunds, A. Camacho, M. Carroll, M. Doumbia, B. Draguez, S. Duraffour and 18 more. The Lancet, 2015
715 citations recorded by the source corpus.
Subfields: Health, Infectious Diseases
View Paper: https://www.semanticscholar.org/paper/5201d16885239a5f037580486822d7a29a144137
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- C. Dendrou
- L. Fugger
- J. Rossjohn
- J. Petersen
Citations in the corpus
- HLA variation and disease (2018, background): “Emerging infections, such as Ebola, Zika and Dengue viruses, highlight the need for rapid vaccine generation and trialling strategies that rely on the efficient identification of appropriate viral epitopes to safely but effectively induce immunogenicity 106,107 .”